Severe Acute Respiratory Syndrome CoronaVirus 2
Showing 26 - 50 of >10,000
Respiratory Distress Syndrome, Adult Trial in United States (Veru-111)
Completed
- Respiratory Distress Syndrome, Adult
-
Scottsdale, Arizona
- +4 more
Nov 22, 2021
Corona Virus Disease 19 (Covid19), Corona Virus Infection, Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2) Trial in
Completed
- Corona Virus Disease 19 (Covid19)
- +2 more
-
Cairo, EgyptAl Assema Hospital
Apr 25, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- COVAC-1
- Saline Placebo
- (no location specified)
Jan 23, 2023
Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- Aspergillosis Invasive
- Isavuconazonium Injection [Cresemba]
- Placebo
-
Orange, California
- +2 more
Jul 26, 2022
PEEP Setting in COVID19-related ARDS
Completed
- ARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2
- PEEP setting
-
Nancy, FranceService de Réanimation Médicale, Hôpital Central
Nov 9, 2021
Ards Trial in Madrid (16-hour PP)
Completed
- Ards
- 16-hour PP
-
Madrid, SpainHospital 12 de Octubre
Oct 27, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
- (no location specified)
Sep 16, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Halifax, Saskatoon (COVAC-2, Saline Placebo)
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
-
Halifax, Nova Scotia, Canada
- +1 more
Aug 5, 2022
COVID-19 Trial in Danderyd (SARS-CoV-2 convalescent plasma)
Completed
- COVID-19
- SARS-CoV-2 convalescent plasma
-
Danderyd, SwedenDanderyd Hospital
Dec 1, 2021
Clinical Features of COVID-19 Patients
Recruiting
- Covid19
- +2 more
- peripheral lymphocytes subsets
-
L'Aquila, ItalySan Salvatore Academic Hospital
Aug 12, 2021
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
Not yet recruiting
- COVID-19 Pneumonia
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- plasmatic SARS-CoV-2 RNA quantification
- (no location specified)
Nov 9, 2021
Using Chinese Medicine During Severe Acute Respiratory Syndrome
Completed
- COVID-19 Pandemic
- Jing-Guan-Fang(JGF) : Chinese herbal decoction
-
Taipei, TaiwanTaipei City Hospital
Feb 12, 2022
Coronavirus Disease 2019 (COVID-19) on Sperm Parameters
Enrolling by invitation
- Covid19
- Infertility, Male
- Sperm analysis
-
Laval, Quebec, CanadaFertilys
Aug 18, 2021
Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial (Stem Cell Educator-Treated Mononuclear Cells Apheresis)
Not yet recruiting
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Stem Cell Educator-Treated Mononuclear Cells Apheresis
- (no location specified)
Jun 25, 2021
Corona Virus Infection, ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2, Oxygen Deficiency Trial
Not yet recruiting
- Corona Virus Infection
- +2 more
- Oxygen theraphy with high flow nasal cannule
- Oxygen theraphy with mask with reservoir
-
Szczecin, Zachodniopomorskie, PolandOxygen Therapy Sector of Temporary Hospital
Jan 18, 2022
Beaumont Health Large-scale Automated Serologic Testing for
Completed
- COVID-19
- +2 more
- EUROIMMUN assay
-
Royal Oak, Michigan
- +1 more
Sep 2, 2021
Non-invasive Oxygenation Strategies in Patients Admitted for
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Use of High Flow Nasal Cannula alone
- +2 more
-
Béthune, Nord-Pas-de-Calais, France
- +3 more
Feb 1, 2022
Covid19 Trial in New Brunswick (OL-1, standard dose, OL-1, high dose, Placebo)
Completed
- Covid19
- OL-1, standard dose
- +2 more
-
New Brunswick, New JerseyRutgers University
Jan 31, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-CoV2
- Janus Kinase Inhibitor (ruxolitinib)
- Placebo
-
Sao Paulo, BrazilHospital das Clínicas
Apr 5, 2021
COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium
Terminated
- COVID-19
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- C19-IG 20%
- 0.9% Sodium chloride
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Feb 9, 2022
Covid19 Trial in Madrid (Probiotic: Lactobacillus salivarius + Vit D + Zinc, Placebo)
Completed
- Covid19
- Probiotic: Lactobacillus salivarius + Vit D + Zinc
- Placebo
-
Madrid, SpainHospital Universitario Infanta Leonor
May 27, 2022
Prone Position During ECMO in Severe Acute Respiratory Syndrome
Completed
- SARS CoV 2 Infection
- Hypoxemic Respiratory Failure
- Prone position on ECMO patient
-
Berkane, Moroccoyounes Oujidi
Aug 6, 2021
COVID-19 Trial (Olokizumab 64 mg, Placebo)
Withdrawn
- COVID-19
- Olokizumab 64 mg
- Placebo
- (no location specified)
Oct 29, 2021
Stratification With Chest CT to Rule-out Suspected SARS-CoV-2
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- CT-imaging
-
Jena, Thuringia, GermanyJena University Hospital
Sep 17, 2021
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Trial in Sumida-ku,
Completed
- Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
- TAK-019
- Placebo
-
Sumida-ku, Tokyo, Japan
- +1 more
Apr 6, 2022